The Role of Factor XI in Coagulation

George J Broze Jr; David Gailani

doi:10.1055/s-0038-1646163

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1993; 70(01): 072-074
DOI: 10.1055/s-0038-1646163

State-of-the-Art Lecture

Factor XI

Schattauer GmbH Stuttgart

The Role of Factor XI in Coagulation

Authors

George J Broze Jr

The Jewish Hospital, Washington University Medical Center, St. Louis, MO, USA
David Gailani

The Jewish Hospital, Washington University Medical Center, St. Louis, MO, USA

Abstract

PDF Download

PDF (896 kb)

References

References
1 MacFarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202: 498-499
2 Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310-1312
3 Kaplan AP, Silverberg M. The coagulation-kinin pathway of human plasma. Blood 1987; 70: 1-15
4 Østerud B, Rapaport S. Activation of factor IX by the reaction product of tissue factor and factor VII. Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-5264
5 Broze Jr GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood 1988; 71: 335-343
6 Broze Jr GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539-7546
7 Rapaport SI. The extrinsic pathway inhibitor: A regulator of tissue factor-dependent blood coagulation. Thromb Haemostas 1991; 66: 6-15
8 Rosenthal RL, Dreskin OH, Rosenthal N. Plasma thromboplastin antecedent (PTA) deficiency: Clinical, coagulation, therapeutic and hereditary aspects of a new hemophilia-like disease. Blood 1955; 10: 120-131
9 Leiba H, Romot B, Many R. Heredity and coagulation studies in ten families with factor XI (plasma thromboplastin antecedent) deficiency. Br J Haematol 1965; 11: 654-665
10 Lewis JH, Spero JA, Ragni MV, Bontempo FA. Transfusion support for congenital clotting deficiencies other than haemophilia. Clin Haematol 1984; 13: 119-135
11 Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor Xl-deficiency kindreds. Blood 1985; 65: 719-724
12 Bolton-Maggs PHB, Young-Wan-Yin R, McCraw A, Slack J, Kernoff PBA. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988; 69: 521-528
13 Litz CE, Swaim WR, Dalmasso AP. Factor XI deficiency: Genetic and clinical studies of a single kindred. Am J Hematol 1988; 28: 8-12
14 Berliner S, Horowitz I, Martinowitz U, Brenner B, Seligsohn U. Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coag Fibrinol 1992; 3: 465-468
15 Komiyama Y, Masuda M, Murakami T, Nishikado H, Egawa H, Nishimura T, Morii S, Murata K. Accumulation of ¹²⁵I-factor XI in atheroma of rabbit with hereditary hyperlipidemia (WHHL-rabbit). Thromb Res 1989; 56: 49-58
16 Loeser WD, Dickstein ES. Factor XI deficiency in a geriatric population. Ohio Med 1988; 84: 416-417
17 Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII: Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 1991; 266: 7353-7358
18 Gailani D, Broze Jr GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-912
19 Bouma BN, Vlooswijk RA, Griffin JH. Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogen. Blood 1983; 62: 1123-1131
20 Scott CF, Colman RW. Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate. Proc Natl Acad Sci USA 1992; 89: 11189-11193
21 Brunnee T, La Porta C, Reddigari SR, Salerno VM, Kaplan AP, Silverberg M. Activation of factor XI in plasma is dependent on factor XII. Blood 1993; 81: 580-586
22 Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin Ill-independent inhibitors. J Clin Invest 1990; 86: 385-391
23 Walsh PN, Griffin JH. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. Blood 1981; 57: 106-118
24 Broze Jr GJ. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol 1992; 29: 159-169